Electromed, Inc. (ELMD)
Electromed, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in New Prague, MN, US. The stock last traded at $42.20, down 0.45% on the session, giving a market capitalisation of $349.4M. On trailing twelve-month figures it carries a trailing P/E of 34.59, a net margin of 14.1%. Its beta of 0.51 implies it has historically moved less than the broad market.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Electromed, Inc. is most often compared with the following Healthcare names: